Skip to main content
. 2021 Jul 20;11(7):1302. doi: 10.3390/diagnostics11071302

Table 1.

Patient treatment characteristics with targeted therapy regimen.

Patient Prior Nephrectomy Sites of Disease/Index Lesions Targeted Therapy Progressive Disease at 6 Months
1 Yes Nodal Sunitinib No
2 Yes Spleen/Stomach Sunitinib No
3 Yes Nodal Sunitinib No
4 Yes Liver (2) Sunitinib Yes
5 Yes Nodal Sunitinib Yes
6 No Kidney Sunitinib No
7 No Kidney Pazopanib No
8 No Kidney Sunitinib No
9 No Kidney Pazopanib No
10 Yes Nephrectomy bed/Nodal Sunitinib No
11 Yes Nodal (2) Sunitinib No
12 Yes Kidney (2)/Liver/Pancreas (2) Pazopanib No
13 No Kidney/Pancreas Sunitinib Yes
14 No Kidney Sunitinib No

() = number of tumours if more than one.